Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lifotronic Technology has developed and commercialized a broad portfolio of medical devices for both diagnosis and therapy. Their products are used in over 15,000 hospitals across more than 100 countries with an installed base exceeding 100,000 systems. The company's offerings include IVD equipment such as HPLC analyzers, ECLIA systems, hematology analyzers; POCT/molecular/rapid test solutions; respiratory & ICU/wound care equipment; electromagnetic/pneumatic shockwave pain management systems; laser hair removal/aesthetic medicine platforms. They have four manufacturing centers in China with capacity to produce up to 100,000 devices annually[1][2].
No clinical trial results are reported since these are regulated as medical devices rather than drugs.
The company went public on the Shanghai Stock Exchange STAR Market under code "688389".
Key people include Xiancheng Liu (Chairman), Ming Long Hu (Director & GM), Min Liu (Chairman of Supervisory Board), Hong Wang (CFO)[3].
Headquarters located in Shenzhen with four factories across mainland China[1][2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lifotronic Technology.